Azacitidine
Showing 1 - 25 of 592
Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
- (no location specified)
Mar 15, 2023
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,
Terminated
- Myelodysplastic Syndromes (MDS)
- +2 more
- NEX-18a injection
- Azacitidine Injection
-
Huddinge, Sweden
- +1 more
Apr 4, 2022
Secondary Acute Myeloid Leukemia Trial in Nanjing (Venetoclax;Azacitidine;Homoharringtonine)
Recruiting
- Secondary Acute Myeloid Leukemia
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Aug 21, 2022
Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine Combined With Venetoclax and ATRA group
-
Suzhou, Chinathe First Affiliated Hospital of Soochow University
Dec 8, 2022
Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)
Not yet recruiting
- Acute Kidney Disease
- Azacitidine
- Placebo
-
Taipei City, TaiwanYu Hsiang Chou
May 2, 2022
Solid Tumor, Gastrointestinal Cancer, Breast Cancer Trial in Singapore (QPOP, CURATE.AI, Azacitidine + docetaxel)
Not yet recruiting
- Solid Tumor
- +2 more
- QPOP
- +4 more
-
Singapore, SingaporeNational University Hospital
May 18, 2022
Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)
Not yet recruiting
- Higher Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
- AMG 176
- Azacitidine
- (no location specified)
Jul 29, 2022
MDS Trial in Saint Louis (vosaroxin, Azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes
- vosaroxin
- Azacitidine
-
Saint Louis, MissouriWashington University School of Medicine
Mar 23, 2022
Venetoclax Combined With Azacitidine Plus Homoharringtonine, Venetoclax Combined With Azacitidine Trial in Guangzhou (VEN
Recruiting
- Venetoclax Combined With Azacitidine Plus Homoharringtonine
- Venetoclax Combined With Azacitidine
- VEN combined with azacitidine plus homoharringtonine
- VEN combined with azacitidine
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 9, 2022
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Azacitidine
- Venetoclax
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Jul 22, 2022
Acute Myeloid Leukemia Trial in Nanjing (Venetoclax-Decitabine/Azacitidine-Aclarubicin Association,
Recruiting
- Acute Myeloid Leukemia
- Venetoclax-Decitabine/Azacitidine-Aclarubicin Association
- Venetoclax-Decitabine/Azacitidine Association
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Mar 2, 2022
Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- Relapsed Adult AML
- Lintuzumab-Ac225
- +2 more
- (no location specified)
Feb 22, 2022
High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)
Recruiting
- High Grade Myelodysplastic Syndromes
- Omacetaxine
- Azacitidine
-
Aurora, ColoradoUniverstiy of Colorado Denver
Oct 19, 2021
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- LP-108
- Azacitidine
- (no location specified)
Nov 29, 2022
T Cell Lymphoma Trial (Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen)
Not yet recruiting
- T Cell Lymphoma
- Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen
- (no location specified)
Mar 6, 2023
Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Venetoclax
-
Aurora, ColoradoUniverstiy of Colorado Hospital
Feb 15, 2022
Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)
Recruiting
- Lymphoma, T-Cell
- Durvalumab
- +3 more
-
Charlottesville, VirginiaUniversity of Virginia
Mar 16, 2022
MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Oral Azacitidine
- Placebo for Oral Azacitidine
-
Buenos Aires, Argentina
- +1 more
Aug 1, 2022
Myeloid Malignancy Trial in Detroit (azacitidine)
Recruiting
- Myeloid Malignancy
- azacitidine
-
Detroit, MichiganHenry ford hospital
Dec 23, 2021
Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)
Recruiting
- Chronic Myeloid Leukemia
- Myelofibroses
- Azacitidine
- Selumetinib
-
Chicago, IllinoisThe University of Chicago
May 16, 2022
MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)
Terminated
- MDS
- Myelodysplastic Syndromes
- APR-548 + Azacitidine
-
Tampa, Florida
- +3 more
Jul 20, 2022
Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)
Recruiting
- Peripheral T Cell Lymphoma
- Mitoxantrone liposome、Chidamide、Azacitidine
-
Zhejiang, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 9, 2022
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- BLU-263
- Azacitidine
- (no location specified)
Nov 2, 2022
Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- venetoclax combining chidamide and azacitidine (VCA)
-
Xiamen, Fujian, ChinaBing Xu
Aug 1, 2022